BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23339663)

  • 1. Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry.
    Carletti E; Colletier JP; Schopfer LM; Santoni G; Masson P; Lockridge O; Nachon F; Weik M
    Chem Res Toxicol; 2013 Feb; 26(2):280-9. PubMed ID: 23339663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.
    Carletti E; Schopfer LM; Colletier JP; Froment MT; Nachon F; Weik M; Lockridge O; Masson P
    Chem Res Toxicol; 2011 Jun; 24(6):797-808. PubMed ID: 21438623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition kinetics of acetylcholinesterase and butyrylcholinesterase from various species by 2-(2-cresyl)-4H-1,3,2-benzodioxaphosphorin-2-oxide (CBDP).
    Horn G; Rappenglück S; Worek F
    Toxicol Lett; 2024 May; 396():28-33. PubMed ID: 38642675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of ortho-cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic-UHPLC-MS/MS.
    Johnson D; Carter MD; Crow BS; Isenberg SL; Graham LA; Erol HA; Watson CM; Pantazides BG; van der Schans MJ; Langenberg JP; Noort D; Blake TA; Thomas JD; Johnson RC
    J Mass Spectrom; 2015 Apr; 50(4):683-92. PubMed ID: 26149113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesterase.
    Liyasova MS; Schopfer LM; Lockridge O
    Chem Biol Interact; 2013 Mar; 203(1):103-7. PubMed ID: 22898212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human cytochrome P450s involved in the bioactivation of tri-ortho-cresyl phosphate (ToCP).
    Reinen J; Nematollahi L; Fidder A; Vermeulen NP; Noort D; Commandeur JN
    Chem Res Toxicol; 2015 Apr; 28(4):711-21. PubMed ID: 25706813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the development of enzyme-based nerve agent bioscavengers.
    Nachon F; Brazzolotto X; Trovaslet M; Masson P
    Chem Biol Interact; 2013 Dec; 206(3):536-44. PubMed ID: 23811386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of neurotoxic effects of tri-cresyl phosphates (TCPs) and cresyl saligenin phosphate (CBDP) using a combination of in vitro techniques.
    Hausherr V; Schöbel N; Liebing J; van Thriel C
    Neurotoxicology; 2017 Mar; 59():210-221. PubMed ID: 27288108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaction kinetics of biotinylated organophosphorus toxicant, FP-biotin, with human acetylcholinesterase and human butyrylcholinesterase.
    Schopfer LM; Voelker T; Bartels CF; Thompson CM; Lockridge O
    Chem Res Toxicol; 2005 Apr; 18(4):747-54. PubMed ID: 15833035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
    Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
    Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying safer anti-wear triaryl phosphate additives for jet engine lubricants.
    Baker PE; Cole TB; Cartwright M; Suzuki SM; Thummel KE; Lin YS; Co AL; Rettie AE; Kim JH; Furlong CE
    Chem Biol Interact; 2013 Mar; 203(1):257-64. PubMed ID: 23085349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies.
    Masson P; Lushchekina S; Schopfer LM; Lockridge O
    Biochem J; 2013 Sep; 454(3):387-99. PubMed ID: 23782236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
    Bosak A; Gazić I; Vinković V; Kovarik Z
    Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
    Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
    Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
    Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
    Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
    Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cholinesterase inhibition of cativic acid derivatives.
    Alza NP; Richmond V; Baier CJ; Freire E; Baggio R; Murray AP
    Bioorg Med Chem; 2014 Aug; 22(15):3838-49. PubMed ID: 25017625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.